Global CAR T-cell Therapy Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Page: 90

Published Date: 13 Jan 2025

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global CAR T-cell Therapy Drug market size was valued at US$ 5337 million in 2024 and is forecast to a readjusted size of USD 31500 million by 2031 with a CAGR of 29.2% during review period.

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
The CAR T-cell therapy drug gel market is driven by the revolutionary approach of CAR T-cell therapy in cancer treatment and the demand for targeted and personalized therapies. CAR T-cell therapy involves genetically modifying a patient"s own T cells to target and destroy cancer cells. The rise in cancer prevalence and the need for innovative treatments contribute to market growth as healthcare providers seek effective and tailored solutions for patients with difficult-to-treat cancers. Moreover, advancements in gel-based drug delivery systems have improved the precision and safety of CAR T-cell therapy administration. However, the market also faces challenges, including complex manufacturing processes and potential side effects associated with immune response. Additionally, addressing the high cost of CAR T-cell therapies and ensuring scalability and accessibility for broader patient populations can pose obstacles for manufacturers and healthcare systems. To succeed, companies must focus on advancing research and development, collaborating with oncologists to optimize therapy protocols, and addressing the challenges to meet the increasing demand for breakthrough cancer treatments.

This report is a detailed and comprehensive analysis for global CAR T-cell Therapy Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global CAR T-cell Therapy Drug market size and forecasts, in consumption value ($ Million), 2020-2031
Global CAR T-cell Therapy Drug market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global CAR T-cell Therapy Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global CAR T-cell Therapy Drug market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CAR T-cell Therapy Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CAR T-cell Therapy Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
CAR T-cell Therapy Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    CD19-targeted
    BCMA-targeted

Market segment by Application
    Lymphoma
    Multiple Myeloma

Market segment by players, this report covers
    Novartis
    Gilead Sciences
    Bristol-Myers Squibb
    J & J
    JW Therapeutics
    FOSUNKite

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CAR T-cell Therapy Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CAR T-cell Therapy Drug, with revenue, gross margin, and global market share of CAR T-cell Therapy Drug from 2020 to 2025.
Chapter 3, the CAR T-cell Therapy Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and CAR T-cell Therapy Drug market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CAR T-cell Therapy Drug.
Chapter 13, to describe CAR T-cell Therapy Drug research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of CAR T-cell Therapy Drug by Type
        1.3.1 Overview: Global CAR T-cell Therapy Drug Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global CAR T-cell Therapy Drug Consumption Value Market Share by Type in 2024
        1.3.3 CD19-targeted
        1.3.4 BCMA-targeted
    1.4 Global CAR T-cell Therapy Drug Market by Application
        1.4.1 Overview: Global CAR T-cell Therapy Drug Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Lymphoma
        1.4.3 Multiple Myeloma
    1.5 Global CAR T-cell Therapy Drug Market Size & Forecast
    1.6 Global CAR T-cell Therapy Drug Market Size and Forecast by Region
        1.6.1 Global CAR T-cell Therapy Drug Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global CAR T-cell Therapy Drug Market Size by Region, (2020-2031)
        1.6.3 North America CAR T-cell Therapy Drug Market Size and Prospect (2020-2031)
        1.6.4 Europe CAR T-cell Therapy Drug Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific CAR T-cell Therapy Drug Market Size and Prospect (2020-2031)
        1.6.6 South America CAR T-cell Therapy Drug Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa CAR T-cell Therapy Drug Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis CAR T-cell Therapy Drug Product and Solutions
        2.1.4 Novartis CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 Novartis Recent Developments and Future Plans
    2.2 Gilead Sciences
        2.2.1 Gilead Sciences Details
        2.2.2 Gilead Sciences Major Business
        2.2.3 Gilead Sciences CAR T-cell Therapy Drug Product and Solutions
        2.2.4 Gilead Sciences CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Gilead Sciences Recent Developments and Future Plans
    2.3 Bristol-Myers Squibb
        2.3.1 Bristol-Myers Squibb Details
        2.3.2 Bristol-Myers Squibb Major Business
        2.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Product and Solutions
        2.3.4 Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.4 J & J
        2.4.1 J & J Details
        2.4.2 J & J Major Business
        2.4.3 J & J CAR T-cell Therapy Drug Product and Solutions
        2.4.4 J & J CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 J & J Recent Developments and Future Plans
    2.5 JW Therapeutics
        2.5.1 JW Therapeutics Details
        2.5.2 JW Therapeutics Major Business
        2.5.3 JW Therapeutics CAR T-cell Therapy Drug Product and Solutions
        2.5.4 JW Therapeutics CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 JW Therapeutics Recent Developments and Future Plans
    2.6 FOSUNKite
        2.6.1 FOSUNKite Details
        2.6.2 FOSUNKite Major Business
        2.6.3 FOSUNKite CAR T-cell Therapy Drug Product and Solutions
        2.6.4 FOSUNKite CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 FOSUNKite Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global CAR T-cell Therapy Drug Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of CAR T-cell Therapy Drug by Company Revenue
        3.2.2 Top 3 CAR T-cell Therapy Drug Players Market Share in 2024
        3.2.3 Top 6 CAR T-cell Therapy Drug Players Market Share in 2024
    3.3 CAR T-cell Therapy Drug Market: Overall Company Footprint Analysis
        3.3.1 CAR T-cell Therapy Drug Market: Region Footprint
        3.3.2 CAR T-cell Therapy Drug Market: Company Product Type Footprint
        3.3.3 CAR T-cell Therapy Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global CAR T-cell Therapy Drug Consumption Value and Market Share by Type (2020-2025)
    4.2 Global CAR T-cell Therapy Drug Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global CAR T-cell Therapy Drug Consumption Value Market Share by Application (2020-2025)
    5.2 Global CAR T-cell Therapy Drug Market Forecast by Application (2026-2031)

6 North America
    6.1 North America CAR T-cell Therapy Drug Consumption Value by Type (2020-2031)
    6.2 North America CAR T-cell Therapy Drug Market Size by Application (2020-2031)
    6.3 North America CAR T-cell Therapy Drug Market Size by Country
        6.3.1 North America CAR T-cell Therapy Drug Consumption Value by Country (2020-2031)
        6.3.2 United States CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        6.3.3 Canada CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        6.3.4 Mexico CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe CAR T-cell Therapy Drug Consumption Value by Type (2020-2031)
    7.2 Europe CAR T-cell Therapy Drug Consumption Value by Application (2020-2031)
    7.3 Europe CAR T-cell Therapy Drug Market Size by Country
        7.3.1 Europe CAR T-cell Therapy Drug Consumption Value by Country (2020-2031)
        7.3.2 Germany CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        7.3.3 France CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        7.3.5 Russia CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        7.3.6 Italy CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific CAR T-cell Therapy Drug Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific CAR T-cell Therapy Drug Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific CAR T-cell Therapy Drug Market Size by Region
        8.3.1 Asia-Pacific CAR T-cell Therapy Drug Consumption Value by Region (2020-2031)
        8.3.2 China CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        8.3.3 Japan CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        8.3.4 South Korea CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        8.3.5 India CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        8.3.7 Australia CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)

9 South America
    9.1 South America CAR T-cell Therapy Drug Consumption Value by Type (2020-2031)
    9.2 South America CAR T-cell Therapy Drug Consumption Value by Application (2020-2031)
    9.3 South America CAR T-cell Therapy Drug Market Size by Country
        9.3.1 South America CAR T-cell Therapy Drug Consumption Value by Country (2020-2031)
        9.3.2 Brazil CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        9.3.3 Argentina CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa CAR T-cell Therapy Drug Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa CAR T-cell Therapy Drug Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa CAR T-cell Therapy Drug Market Size by Country
        10.3.1 Middle East & Africa CAR T-cell Therapy Drug Consumption Value by Country (2020-2031)
        10.3.2 Turkey CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
        10.3.4 UAE CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 CAR T-cell Therapy Drug Market Drivers
    11.2 CAR T-cell Therapy Drug Market Restraints
    11.3 CAR T-cell Therapy Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 CAR T-cell Therapy Drug Industry Chain
    12.2 CAR T-cell Therapy Drug Upstream Analysis
    12.3 CAR T-cell Therapy Drug Midstream Analysis
    12.4 CAR T-cell Therapy Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global CAR T-cell Therapy Drug Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global CAR T-cell Therapy Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global CAR T-cell Therapy Drug Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global CAR T-cell Therapy Drug Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. Novartis Company Information, Head Office, and Major Competitors
 Table 6. Novartis Major Business
 Table 7. Novartis CAR T-cell Therapy Drug Product and Solutions
 Table 8. Novartis CAR T-cell Therapy Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. Novartis Recent Developments and Future Plans
 Table 10. Gilead Sciences Company Information, Head Office, and Major Competitors
 Table 11. Gilead Sciences Major Business
 Table 12. Gilead Sciences CAR T-cell Therapy Drug Product and Solutions
 Table 13. Gilead Sciences CAR T-cell Therapy Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. Gilead Sciences Recent Developments and Future Plans
 Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
 Table 16. Bristol-Myers Squibb Major Business
 Table 17. Bristol-Myers Squibb CAR T-cell Therapy Drug Product and Solutions
 Table 18. Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. J & J Company Information, Head Office, and Major Competitors
 Table 20. J & J Major Business
 Table 21. J & J CAR T-cell Therapy Drug Product and Solutions
 Table 22. J & J CAR T-cell Therapy Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. J & J Recent Developments and Future Plans
 Table 24. JW Therapeutics Company Information, Head Office, and Major Competitors
 Table 25. JW Therapeutics Major Business
 Table 26. JW Therapeutics CAR T-cell Therapy Drug Product and Solutions
 Table 27. JW Therapeutics CAR T-cell Therapy Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. JW Therapeutics Recent Developments and Future Plans
 Table 29. FOSUNKite Company Information, Head Office, and Major Competitors
 Table 30. FOSUNKite Major Business
 Table 31. FOSUNKite CAR T-cell Therapy Drug Product and Solutions
 Table 32. FOSUNKite CAR T-cell Therapy Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. FOSUNKite Recent Developments and Future Plans
 Table 34. Global CAR T-cell Therapy Drug Revenue (USD Million) by Players (2020-2025)
 Table 35. Global CAR T-cell Therapy Drug Revenue Share by Players (2020-2025)
 Table 36. Breakdown of CAR T-cell Therapy Drug by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 37. Market Position of Players in CAR T-cell Therapy Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 38. Head Office of Key CAR T-cell Therapy Drug Players
 Table 39. CAR T-cell Therapy Drug Market: Company Product Type Footprint
 Table 40. CAR T-cell Therapy Drug Market: Company Product Application Footprint
 Table 41. CAR T-cell Therapy Drug New Market Entrants and Barriers to Market Entry
 Table 42. CAR T-cell Therapy Drug Mergers, Acquisition, Agreements, and Collaborations
 Table 43. Global CAR T-cell Therapy Drug Consumption Value (USD Million) by Type (2020-2025)
 Table 44. Global CAR T-cell Therapy Drug Consumption Value Share by Type (2020-2025)
 Table 45. Global CAR T-cell Therapy Drug Consumption Value Forecast by Type (2026-2031)
 Table 46. Global CAR T-cell Therapy Drug Consumption Value by Application (2020-2025)
 Table 47. Global CAR T-cell Therapy Drug Consumption Value Forecast by Application (2026-2031)
 Table 48. North America CAR T-cell Therapy Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 49. North America CAR T-cell Therapy Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 50. North America CAR T-cell Therapy Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 51. North America CAR T-cell Therapy Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 52. North America CAR T-cell Therapy Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 53. North America CAR T-cell Therapy Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 54. Europe CAR T-cell Therapy Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 55. Europe CAR T-cell Therapy Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 56. Europe CAR T-cell Therapy Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 57. Europe CAR T-cell Therapy Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 58. Europe CAR T-cell Therapy Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 59. Europe CAR T-cell Therapy Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 60. Asia-Pacific CAR T-cell Therapy Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 61. Asia-Pacific CAR T-cell Therapy Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 62. Asia-Pacific CAR T-cell Therapy Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 63. Asia-Pacific CAR T-cell Therapy Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 64. Asia-Pacific CAR T-cell Therapy Drug Consumption Value by Region (2020-2025) & (USD Million)
 Table 65. Asia-Pacific CAR T-cell Therapy Drug Consumption Value by Region (2026-2031) & (USD Million)
 Table 66. South America CAR T-cell Therapy Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 67. South America CAR T-cell Therapy Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 68. South America CAR T-cell Therapy Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 69. South America CAR T-cell Therapy Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 70. South America CAR T-cell Therapy Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 71. South America CAR T-cell Therapy Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 72. Middle East & Africa CAR T-cell Therapy Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 73. Middle East & Africa CAR T-cell Therapy Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 74. Middle East & Africa CAR T-cell Therapy Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 75. Middle East & Africa CAR T-cell Therapy Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 76. Middle East & Africa CAR T-cell Therapy Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 77. Middle East & Africa CAR T-cell Therapy Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 78. Global Key Players of CAR T-cell Therapy Drug Upstream (Raw Materials)
 Table 79. Global CAR T-cell Therapy Drug Typical Customers


List of Figures
 Figure 1. CAR T-cell Therapy Drug Picture
 Figure 2. Global CAR T-cell Therapy Drug Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global CAR T-cell Therapy Drug Consumption Value Market Share by Type in 2024
 Figure 4. CD19-targeted
 Figure 5. BCMA-targeted
 Figure 6. Global CAR T-cell Therapy Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 7. CAR T-cell Therapy Drug Consumption Value Market Share by Application in 2024
 Figure 8. Lymphoma Picture
 Figure 9. Multiple Myeloma Picture
 Figure 10. Global CAR T-cell Therapy Drug Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 11. Global CAR T-cell Therapy Drug Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 12. Global Market CAR T-cell Therapy Drug Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 13. Global CAR T-cell Therapy Drug Consumption Value Market Share by Region (2020-2031)
 Figure 14. Global CAR T-cell Therapy Drug Consumption Value Market Share by Region in 2024
 Figure 15. North America CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 16. Europe CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 17. Asia-Pacific CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 18. South America CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 19. Middle East & Africa CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 20. Company Three Recent Developments and Future Plans
 Figure 21. Global CAR T-cell Therapy Drug Revenue Share by Players in 2024
 Figure 22. CAR T-cell Therapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 23. Market Share of CAR T-cell Therapy Drug by Player Revenue in 2024
 Figure 24. Top 3 CAR T-cell Therapy Drug Players Market Share in 2024
 Figure 25. Top 6 CAR T-cell Therapy Drug Players Market Share in 2024
 Figure 26. Global CAR T-cell Therapy Drug Consumption Value Share by Type (2020-2025)
 Figure 27. Global CAR T-cell Therapy Drug Market Share Forecast by Type (2026-2031)
 Figure 28. Global CAR T-cell Therapy Drug Consumption Value Share by Application (2020-2025)
 Figure 29. Global CAR T-cell Therapy Drug Market Share Forecast by Application (2026-2031)
 Figure 30. North America CAR T-cell Therapy Drug Consumption Value Market Share by Type (2020-2031)
 Figure 31. North America CAR T-cell Therapy Drug Consumption Value Market Share by Application (2020-2031)
 Figure 32. North America CAR T-cell Therapy Drug Consumption Value Market Share by Country (2020-2031)
 Figure 33. United States CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 34. Canada CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 35. Mexico CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 36. Europe CAR T-cell Therapy Drug Consumption Value Market Share by Type (2020-2031)
 Figure 37. Europe CAR T-cell Therapy Drug Consumption Value Market Share by Application (2020-2031)
 Figure 38. Europe CAR T-cell Therapy Drug Consumption Value Market Share by Country (2020-2031)
 Figure 39. Germany CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 40. France CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 41. United Kingdom CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 42. Russia CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 43. Italy CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 44. Asia-Pacific CAR T-cell Therapy Drug Consumption Value Market Share by Type (2020-2031)
 Figure 45. Asia-Pacific CAR T-cell Therapy Drug Consumption Value Market Share by Application (2020-2031)
 Figure 46. Asia-Pacific CAR T-cell Therapy Drug Consumption Value Market Share by Region (2020-2031)
 Figure 47. China CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 48. Japan CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 49. South Korea CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 50. India CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 51. Southeast Asia CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 52. Australia CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 53. South America CAR T-cell Therapy Drug Consumption Value Market Share by Type (2020-2031)
 Figure 54. South America CAR T-cell Therapy Drug Consumption Value Market Share by Application (2020-2031)
 Figure 55. South America CAR T-cell Therapy Drug Consumption Value Market Share by Country (2020-2031)
 Figure 56. Brazil CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 57. Argentina CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 58. Middle East & Africa CAR T-cell Therapy Drug Consumption Value Market Share by Type (2020-2031)
 Figure 59. Middle East & Africa CAR T-cell Therapy Drug Consumption Value Market Share by Application (2020-2031)
 Figure 60. Middle East & Africa CAR T-cell Therapy Drug Consumption Value Market Share by Country (2020-2031)
 Figure 61. Turkey CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 62. Saudi Arabia CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 63. UAE CAR T-cell Therapy Drug Consumption Value (2020-2031) & (USD Million)
 Figure 64. CAR T-cell Therapy Drug Market Drivers
 Figure 65. CAR T-cell Therapy Drug Market Restraints
 Figure 66. CAR T-cell Therapy Drug Market Trends
 Figure 67. Porters Five Forces Analysis
 Figure 68. CAR T-cell Therapy Drug Industrial Chain
 Figure 69. Methodology
 Figure 70. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite

Related Reports

Global CAR T-cell Therapy Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global CAR T-cell Therapy Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 06 Feb 2023

date Pharma & Healthcare

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer

Global CAR T-cell Therapy Drug Supply, Demand and Key Producers, 2023-2029

Global CAR T-cell Therapy Drug Supply, Demand and Key Producers, 2023-2029

date 03 Feb 2023

date Pharma & Healthcare

The global CAR T-cell Therapy Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global CAR T-cell Therapy Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global CAR T-cell Therapy Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 05 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global CAR T-cell Therapy Drug market size was valued at USD 2887 million in 2023 and is forecast to a readjusted size of USD 16810 million by 2030 with a CAGR of 28.6% during review period.

Global CAR T-cell Therapy Drug Supply, Demand and Key Producers, 2024-2030

Global CAR T-cell Therapy Drug Supply, Demand and Key Producers, 2024-2030

date 24 Feb 2024

date Pharma & Healthcare

The global CAR T-cell Therapy Drug market size is expected to reach $ 16810 million by 2030, rising at a market growth of 28.6% CAGR during the forecast period (2024-2030).

Product Tags

CAR T-cell Therapy Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>